Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseases
P Touraine, N Youssef, M A Alyanakian, et al.
British Journal of Cancer
|
April 10, 2014
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
C Daveau, S Baulies, M Lalloum, et al.
Plos One
|
May 5, 2021
Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region
Leah G Jarsberg, Komal Kedia, Jason Wendler, et al.
Journal of Clinical Microbiology
|
September 28, 2018
A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis
George B Sigal, Abraham Pinter, Todd L Lowary, et al.
Plos One
|
September 4, 2025
Correction: Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region
Leah G Jarlsberg, Komal Kedia, Jason Wendler, et al.
British Journal of Cancer
|
September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
L de Plater, A Laugé, C Guyader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 13, 2018
Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
Komal Kedia, Jason P Wendler, Erin S Baker, et al.
Clinical Chemistry and Laboratory Medicine
|
February 16, 2022
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
Annie Ren, Dorsa Sohaei, Antigona Ulndreaj, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Endocrinology and Metabolism
|
June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseases
P Touraine, N Youssef, M A Alyanakian, et al.
British Journal of Cancer
|
April 10, 2014
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
C Daveau, S Baulies, M Lalloum, et al.
Plos One
|
May 5, 2021
Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region
Leah G Jarsberg, Komal Kedia, Jason Wendler, et al.
Journal of Clinical Microbiology
|
September 28, 2018
A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis
George B Sigal, Abraham Pinter, Todd L Lowary, et al.
Plos One
|
September 4, 2025
Correction: Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region
Leah G Jarlsberg, Komal Kedia, Jason Wendler, et al.
British Journal of Cancer
|
September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
L de Plater, A Laugé, C Guyader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 13, 2018
Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
Komal Kedia, Jason P Wendler, Erin S Baker, et al.
Clinical Chemistry and Laboratory Medicine
|
February 16, 2022
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
Annie Ren, Dorsa Sohaei, Antigona Ulndreaj, et al.
Page
of 9